Hypertension (High Blood Pressure)
Written by Dr Tashi Zhaxiduojie FRACP PhD · Updated June 2025
Hypertension affects 1 in 3 Australian adults and is the leading modifiable cardiovascular risk factor. Silent in most patients, it silently damages the heart, brain and kidneys over years — making specialist assessment and optimal treatment essential.
Overview
What is hypertension?
Hypertension (high blood pressure) is defined as consistently elevated blood pressure ≥140/90 mmHg in clinic, or ≥135/85 mmHg on home monitoring. It affects approximately 1 in 3 Australian adults and is the leading modifiable risk factor for heart attack, stroke, heart failure and chronic kidney disease worldwide.
Blood pressure classification
| Category | Systolic | Diastolic |
|---|---|---|
| Optimal | <120 | <80 |
| Normal | 120–129 | 80–84 |
| High normal | 130–139 | 85–89 |
| Stage 1 hypertension | 140–159 | 90–99 |
| Stage 2 hypertension | 160–179 | 100–109 |
| Stage 3 / severe | ≥180 | ≥110 |
Based on 2023 European Society of Hypertension guidelines.
Causes & Why It's Silent
Hypertension is called the "silent killer" because most people have no symptoms until organ damage occurs — sometimes decades later.
When symptoms do occur
- Headache (especially in severe hypertension or hypertensive urgency)
- Visual disturbance
- Epistaxis (nosebleed)
- Breathlessness (hypertensive heart disease or heart failure)
- Palpitations
Causes
Primary (essential) hypertension — no identifiable single cause. Accounts for 90–95% of cases. Multifactorial: genetic susceptibility, obesity, salt intake, physical inactivity, alcohol, ageing.
Secondary hypertension — identifiable underlying condition. Accounts for 5–10% and should be suspected in young patients, resistant hypertension or with clinical clues:
- Primary aldosteronism (most common secondary cause)
- Renovascular hypertension (renal artery stenosis)
- Chronic kidney disease
- Obstructive sleep apnoea
- Phaeochromocytoma
- Cushing's syndrome
- Coarctation of the aorta
- Medication-related (NSAIDs, OCP, stimulants)
How It's Measured & Diagnosed
Diagnosis requires multiple elevated readings on separate occasions. A single elevated reading is not diagnostic. Consider:
- Home blood pressure monitoring (HBPM): Average of 7-day readings (morning and evening). More reproducible than clinic measurements. Avoids white-coat effect.
- 24-hour ambulatory BP monitoring (ABPM): Provides nocturnal dipping data (non-dipper/riser pattern associated with worse outcomes).
- Echocardiogram: Assesses for left ventricular hypertrophy (LVH), diastolic dysfunction and hypertensive cardiomyopathy.
- Blood tests: Renal function, electrolytes, fasting glucose, lipid profile, aldosterone/renin ratio (if secondary hypertension suspected).
- Urinalysis: Proteinuria or haematuria may indicate renal involvement or secondary cause.
- Fundoscopy / eye review: Hypertensive retinopathy indicates end-organ damage.
Treatment & Targets
Blood pressure targets (2024 guidelines)
- General adults: <130/80 mmHg
- Older adults (>80 years): 130–139/70–79 mmHg (cautious to avoid hypotension)
- Diabetes: <130/80 mmHg
- Chronic kidney disease: <130/80 mmHg
- Established CVD: <130/80 mmHg
First-line antihypertensive medications
- ACE inhibitors / ARBs: Preferred for diabetes, CKD, heart failure, post-MI.
- Calcium channel blockers (CCBs): Amlodipine, lercanidipine. Effective and well-tolerated. First-line especially in the elderly.
- Thiazide/thiazide-like diuretics: Indapamide preferred over HCTZ. Effective in combination therapy.
- Combination therapy: Most patients require 2–3 agents. Fixed-dose combinations improve adherence.
Resistant hypertension
Defined as BP uncontrolled on 3 antihypertensive medications (including a diuretic) at optimal doses. Requires specialist evaluation to exclude secondary causes and consider adding spironolactone, doxazosin or renal denervation.
Why Treatment Matters
- Each 10 mmHg reduction in systolic BP reduces stroke risk by ~35% and coronary event risk by ~25%
- Well-controlled hypertension significantly reduces risk of heart failure, CKD progression and dementia
- Hypertension with LVH carries a markedly elevated cardiovascular risk independent of BP level
- Long-term adherence to therapy is the key determinant of outcomes — treatment is generally lifelong
Lifestyle Changes
- Reduce sodium intake to <5 g/day (approximately 1 teaspoon of salt)
- DASH diet (Dietary Approaches to Stop Hypertension) — rich in fruits, vegetables, whole grains, low-fat dairy
- Regular aerobic exercise — 150 min/week of moderate intensity reduces BP by 4–9 mmHg
- Weight loss — every 1 kg of weight loss reduces BP by ~1 mmHg
- Alcohol reduction — limit to ≤2 standard drinks/day
- Stress reduction techniques
- Stop smoking (smoking causes acute BP rises and long-term vascular damage)
See a specialist cardiologist in Perth
HeartWise Cardiology — GP referral required.